Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics Register
Data up to Jan 2025
Total Citations Per Year
Abstract
References (38)
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 • 8,367 citations
Inflammation in atherosclerosis
2002 • 7,873 citations
Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis
1995 • 5,929 citations
Inflammation in Atherosclerosis
2012 • 3,528 citations
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
1990 • 2,566 citations
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
1999 • 2,358 citations
Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
2000 • 2,092 citations
Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial
2003 • 1,750 citations
Development and validation of the european league against rheumatism response criteria for rheumatoid arthritis: Comparison with the preliminary american college of rheumatology and the world health organization/international league against rheumatism criteria
1996 • 1,548 citations
Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart Failure
2003 • 1,504 citations
Contribution of trends in survival and coronar y-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations
1999 • 1,457 citations
Etanercept Therapy in Rheumatoid Arthritis
1999 • 1,407 citations
International statistical classification of diseases and related health problems. Tenth revision.
1988 • 1,382 citations
High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors
2001 • 1,296 citations
Cardiovascular Morbidity and Mortality in Women Diagnosed With Rheumatoid Arthritis
2003 • 1,223 citations
Deprivation
1987 • 1,060 citations
High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors
2001 • 1,040 citations
Cardiovascular death in rheumatoid arthritis: A population‐based study
2005 • 935 citations
Explaining How “High-Grade” Systemic Inflammation Accelerates Vascular Risk in Rheumatoid Arthritis
2003 • 922 citations
Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: A population‐based cohort study
2005 • 914 citations
Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure
2000 • 778 citations
Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.
2005 • 532 citations
STANFORD HEALTH ASSESSMENT QUESTIONNAIRE MODIFIED TO ASSESS DISABILITY IN BRITISH PATIENTS WITH RHEUMATOID ARTHRITIS
1986 • 487 citations
Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction
2000 • 423 citations
Mortality in early inflammatory polyarthritis: Cardiovascular mortality is increased in seropositive patients
2002 • 368 citations
Update on the British Society for Rheumatology guidelines for prescribing TNF blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001)
2005 • 340 citations
Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well.
1998 • 327 citations
Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis.
2003 • 300 citations
Stress-Activated Cytokines and The Heart: From Adaptation to Maladaptation
2003 • 291 citations
All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database.
2003 • 288 citations
Baseline levels of c‐reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis : A ten‐year followup study of a primary care–based inception cohort
2005 • 283 citations
British Society for Rheumatology Biologics Register
2003 • 239 citations
Cytokines and hemostasis.
2000 • 227 citations
The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis
2004 • 79 citations
Inflammation, thrombosis and acute coronary syndromes
2005 • 69 citations
The British Society for Rheumatology Biologics Register
2005 • 67 citations
Insights into the Molecular Mechanisms of Plaque Rupture and Thrombosis
2006 • 11 citations
Deleted Work
1955 • 0 citations